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With advancements in nanotechnology, silver has been engineered into a nanometre size and has attracted
great research interest for use in the treatment of wounds. Silver nanoparticles (AgNPs) have emerged as a
potential alternative to conventional antibiotics because of their potential antimicrobial property. However,
AgNPs also induce cytotoxicity, generate reactive oxygen species (ROS), and cause mitochondrial damage to
human cells. Pyridoxine possesses antioxidant and cell proliferation activity. Therefore, in the present
investigation, a nanosilver-pyridoxine complex (AgPyNP) was synthesized, and its cytotoxicity and immune
response was compared with AgNPs in macrophage RAW264.7 cells. Results revealed that AgPyNPs showed less
cytotoxicity compared with AgNPs by producing a smaller amount of ROS in RAW264.7 cells. Surprisingly, however,
AgPyNPs caused macrophage RAW264.7 cells to secrete a larger amount of interleukin-8 (IL-8) and generate a more
active inflammatory response compared to AgNPs. It activated TNF-α, NF-κB p65, and NF-κB p50 to generate a more
vigorous immune protection that produces a greater amount of IL-8 compared to AgNPs. Overall findings indicate that
AgPyNPs exhibited less cytotoxicity and evoked a greater immune response in macrophage RAW264.7 cells. Thus, it
can be used as a better wound-healing agent than AgNPs.
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Bacterial infections are still a leading cause of death for
millions of people worldwide. Infections into wound
areas are very common and have caused people
immense suffering. Moreover, pathogens have evolved
effective approaches to counteract the biocidal action of
antibacterial molecules and developed multidrug-
resistant strains. As a result, even though many antibi-
otics have been developed, very few of them have proved
effective against multidrug-resistant bacteria. Recently,
nanoparticles have been successfully used to deliver
therapeutic agents in chronic disease diagnostics, reduce
bacterial infections, and act as an antimicrobial agent in
the food and clothing industries [1-4]. Silver nanoparti-
cles (AgNPs) have received intensive interest among all
of the leading nanotechnology products existing* Correspondence: jmsong@snu.ac.kr
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in any medium, provided the original work is pcurrently, mainly because of their excellent antimicrobial
properties and various applications in the medical field
[5-7]. Recently, silver nanoparticles have been attracting
interest for their clinical applications because of their
wound-healing efficacy, which could be exploited in
developing better dressings for wounds and ulcers. For
topical applications in wound-healing, AgNPs have gar-
nered much attention as antibacterial agents [8-10].
Wound-healing is a complicated procedure involving a
combination of activities of different tissues and cell lin-
eages. On injury to the epidermis, a sequence of events
is set in motion to repair the wound: the inflammation
phase, proliferation phase, and maturation phase. The
biochemical mechanisms underlying the wound-healing
process involve a number of cytokines and growth fac-
tors. These soluble mediators act to regulate chemotaxis,
migration, growth, and differentiation of the various cell
types present at the injured site. The inflammatory phase
starts within minutes after the skin injury, simultaneously
with haemostasis. The first inflammatory response isOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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migrate through the endothelium of the local blood vessels
to the wound. The next response is carried out by mono-
cytes, which differentiate into macrophages in the tissues
after entering by a mechanism similar to that of neutro-
phils. These macrophages secrete cytokines and, in this
way, initiate an inflammatory response, which results in
more cells of the immune system at the place of infection
[11]. Tissue macrophages are distributed throughout the
whole body and secrete large pools of cytokines when they
encounter foreign materials. Cytokines are known as
biological-response modifiers that modulate inflammation,
immunity, and hematopoiesis. Among them, interleukin-8
(IL-8) is an important cytokine involved in inflammation
and postnatal wound-healing by recruiting neutrophils to
acute inflammation sites [12]. IL-8 stimulates the chemo-
taxis of neutrophils and keratinocytes. High concentra-
tions of IL-8 have been observed in burn-wound fluid
[13-15]. It has also been reported that silver nanoparticles
triggered macrophages to release IL-8 [16]. Despite the
rapidly increasing application of AgNPs worldwide, they
are highly toxic to various types of cultured cells. It has
been reported that AgNP-induced cytotoxicity by produ-
cing reactive oxygen species (ROS) and increasing lactate
dehydrogenase (LDH) leakage, causing mitochondrial
damage and DNA damage [16-19]. Therefore, it is critical
to design and develop new therapeutic agents to overcome
the silver nanoparticles’ cytotoxicity issues related to
wound-healing, as well as antimicrobial activity.
Pyridoxine, a form of vitamin B6, is commonly used as
a dietary supplement and therapeutic agent. It plays an
important role in maintaining muscle tone in the gastro-
intestinal tract and promoting the health of the nervous
system, skin (preventing dandruff, eczema, and psoriasis),
hair, eyes, mouth, and liver. Pyridoxine is essential to
normal brain development, participates in the biosyn-
thesis of neurotransmitters, and also controls homo-
cysteine levels in the blood. High levels of homocystein
in the blood can be detrimental to the heart muscle.
Pyridoxine also possesses antioxidant activity [20] and
cell proliferation facilitation properties [21,22].
The main aim of this study was to prepare a
nanosilver-pyridoxine complex (AgPyNP) and investigate
its ROS-production-based antimicrobial activity, cyto-
toxicity, and inflammatory action related to its wound-
healing ability in the RAW264.7 macrophage cell line.
AgNPs were used as a model of comparison for the
novel nanoparticle. Discovery of a new nanoparticle that
causes more vigorous inflammatory action and less cyto-
toxicity than AgNPs while its antibacterial activity is
maintained as a topical therapeutic agent, will pave the
way for the next generation of therapeutic nanoparticles.
Macrophage cells were used for this study to assess the
inflammatory response of AgPyNPs, as well as AgNPs.Methods
Dulbecco’s modified Eagle’s medium (DMEM), fetal bo-
vine serum (FBS), penicillin, streptomycin, neomycin
(PSN) antibiotic, trypsin, and ethylenediaminetetraacetic
acid (EDTA) were purchased from Gibco BRL (Grand
Island, NY, USA). Tissue culture plastic wares were ob-
tained from BD Biosciences (San Jose, CA, USA). Pro-
pidium iodide; acrydine orange; 4′,6′-diamidino-2
phenylindole (DAPI); 3-(4,5-Dimethylthiazol-2 yl)-2,
S-diphenyltetrazolium bromide (MTT); and all other
chemicals used were purchased from Sigma-Aldrich
Co. (St. Louis, MO, USA). All organic solvents used
were of HPLC grade. Pyridoxine, silver nitrate
(AgNO3), ammonium hydroxide (NH4OH), ammonium
persulfate ((NH4)2S2O8), dioctyl sulfosuccinate (AOT),
dimethyl sulfoxide (DMSO), sodium citrate, sodium boro-
hydride (NaBH4), polyvinylpyrrolidone (PVP), and heptane
utilized for the synthesis of nanoparticles were also pur-
chased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Synthesis of AgNPs
Small-sized, highly monodispersed AgNPs were synthe-
sized according to the modified literature procedure by
Pham Van Dong et al. by reducing aqueous AgNO3 in
the presence of NaBH4 and PVP as reducing and stabil-
izing agents. Briefly, an aqueous solution of sodium
citrate (0.25 mL, 15 mM) was added to a flask contain-
ing 25 mL of deionized water. Then, aqueous solution of
AgNO3 (0.5 mL, 2.5 mM) was added and gently mixed.
Freshly prepared NaBH4 (0.25 mL, 25 mM) was rapidly
added and allowed to stir for 30 s. Finally, aqueous solu-
tion of PVP (0.25 mL, 2.5 mg/mL) was added to the sus-
pension and stirred further for 30 min. Dark yellow
coloured suspension was centrifuged and the pellet was
dried under vacuum. Absorption spectroscopy is primar-
ily used for the structural characterization of AgNPs.
From the absorption spectrum, the surface plasmon res-
onance peaks of the silver nanoparticles were observed
around 420 nm, confirming the formation of spherical
silver nanoparticles (Figure 1b). The size and morph-
ology of nanoparticles were analysed by transmission
electron microscope (TEM). The TEM images con-
firmed the monodispersity of nanoparticles (Figure 1c).
The size-distribution analysis was used to determine the
average particle size at 20 nm (Figure 1d).
Synthesis of AgPyNPs
AgPyNPs were synthesized by a modified reverse micro-
emulsion (W/O) technique. To perform a complexation
reaction under the condition of microemulsion, AgNO3,
pyridoxine, and ammonium persulfate were taken at a
1:4:4 mole ratio. W/O microemulsion was initiated by
dissolving AOT (0.44 g, 0.1 M) surfactant in 10 mL
heptane. Then, pyridoxine (3.9 mg) was dissolved in
Figure 1 (See legend on next page.)
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Figure 1 Chemical structure, absorption spectra, TEM image, and size-distribution analyses. (a) Chemical structure of nanosized silver (II)
pyridoxine complex; (b) absorption spectra of AgNPs and AgPyNPs; (c) TEM image of AgNPs and AgPyNPs synthesized by a modified citrate-reduction
method and reverse microemulsion method, respectively; (d) size distribution analysis of synthesized nanoparticles. AgNPs, silver nanoparticles; AgPyNPs,
nanosilver-pyridoxine complexes.
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(29 μL) was added to the heptane solution to form a
stable microemulsion. Ammonium hydroxide (5.8 μL,
29 wt.%) was added to the reaction mixture and gently
stirred for 30 min. The microemulsion solution turned
brown, indicating the oxidation of silver to a higher
valence state. The microemulsion solution was allowed
to stir for another 24 h. AgPyNPs were isolated by disin-
tegrating the microemulsion solution using ethanol or
acetone. The nanoparticles were recovered by centrifu-
gation. Finally, nanoparticles were washed twice with
methanol to remove the unreacted starting materials,
surfactants, and organic solvent. Then, nanoparticles
were dried under vacuum and stored as a powder under
room temperature. Figure 1b shows the electronic ab-
sorption spectrum of AgPyNPs. The nanosized complex
formation between silver and pyridoxine ligand (Py) was
confirmed through the analysis of the spectrum.
AgPyNPs exhibit different absorption patterns compared
to that of Py. AgPyNPs showed strong absorption in the
wavelength region larger than 300 nm. The characteris-
tic peaks at 345 and 400 nm were also present as shoul-
ders. Nanoparticle formation was further confirmed by
TEM. Figure 1c shows the monodispersed AgPyNPs and
their average particle size was determined to be 20 nm
(Figure 1d).
1H NMR (500 MHz, DMSO-d6) 7.86 (s, 2H), 4.71 (s,
4H), 4.47 (s, 4H), 2.39 (s, 6H); IR (KBr, cm−1) 3432.67 (s,
vOH), 1631.48 (w, vCO
− ), 1403.92 (m, vC-C); EA (C, H, N)
Anal. Calcd for C16H20N2O7Ag: Ag, 23.44; C, 41.76; H,
4.38; N, 6.09; O, 24.34. Found: Ag, 23.35; C, 41.71; H, 4.
32; N, 6.15; O, 24.39. FAB-MS (m/z): 460.21.
Cell culture
RAW264.7 cells (KCLB®, Seoul, South Korea) were cultured
in standard (DMEM) medium (Gibco, Grand Island, NY,
USA) supplemented with heat-inactivated 10% FBS (Gibco,
Grand Island, NY, USA), penicillin (60 μg/mL), and strepto-
mycin (100 μg/mL) solutions in cell-culture flasks (75 cm2).
Cells were grown at 37°C in a humidified incubator con-
taining 5% CO2 (US AutoFlowt, NuAire, Plymouth, MN,
USA). After the cells attained confluence, they were subcul-
tured following trypsinization with a 0.25% trypsin-EDTA
solution (Gibco, Grand Island, NY, USA).
MTT assay
To determine the effect of AgNPs and AgPyNPs on
RAW264.7 cell growth, cultured cells were treated withdifferent doses of AgNPs and AgPyNPs ranging up to
70 μg/mL. After 24 h of treatment, cell viability was
assessed using MTT assay. The intracellular formazan
crystals formed were solubilized with acidic isopropanol,
and the absorbance of the solution was measured at
595 nm. Percentage viability was calculated as follows:
(OD of drug treated sample/OD of control sample) × 100.Measurement of intracellular ROS
Estimation of intracellular ROS was performed using
cell-permeable fluorescent-probe 2′-7′-dichlorofluores-
cein-diacetate (DCFDA), a non-fluorescent compound,
which is converted into highly fluorescent dichlorofluor-
escein (DCF) by cellular peroxides. Cells, after being
treated with AgNPs/AgPyNPs for the desired amount of
time, were loaded with 10 μM DCFDA. Following the
incubation period at 37°C for 30 min in the dark, cells
were washed with PBS and fluorescence-monitored with
a fluorescence microscope (Axisocope Plus 2, Zeiss,
Jena, Germany). The level of intracellular ROS was also
measured by FACS with an excitation wavelength of
480 nm and an emission wavelength of 530 nm using
the same fluorescence probe.
Analysis of IL-8 release
The expression level of IL-8 secretion of AgNP- and
AgPyNP-treated RAW264.7 cells were analysed by the
ELISA method using an IL-8 assay kit (R&D systems,
Minneapolis, USA) according to the manufacturer’s
protocol.
Effect of AgNPs and AgPyNPs on TNF-α, NF-κB p65, and
NF-κB p50 expression
AgNP/AgPyNP-induced expressions of TNF-α, NF-κB
p65, and NF-κB p50 in RAW264.7 cells were monitored
using quantitative cellular imaging cytometry. TNF-α,
NF-κB p65, and NF-κB p50 antibodies were purchased
from BD Biosciences (San Jose, CA, USA) and followed
by conjugate with quantum-dot according to the manu-
facturer’s protocol (Life Science Technology, Grand
Island, NY, USA). After AgNP/AgPyNP treatment, cells
were washed with PBS and incubated with quantum-
dot-conjugated TNF-α, NF-κB p65, and NF-κB p50 anti-
bodies according to the protocol. The emission maxima
for TNF-α, NF-κB p65, and NF-κB p50 at 525, 565, and
625 nm, respectively, were imaged using an AOTF
microscope.
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Cell viability assay
Cell viability assay was performed by MTTassay using dif-
ferent dosages of AgNPs/AgPyNPs in RAW264.7cells after
24 h of treatment. Untreated cells served as controls. The
results of the MTT assay are shown in Figure 2. Both
AgNPs/AgPyNPs showed their cytotoxicity at concentra-
tions of 50 μg/mL and higher. AgNPs exhibited greater
cytotoxicity compared to that of AgPyNPs. The 84.1%,
68.78%, 30.79%, and 21.56% viable cells were observed
after 5, 10, 50, and 70 μg/mL AgNP treatments, respect-
ively. Whereas, 92.96%, 76.28%, 46.47%, and 33.99% viable
cells were observed after 5, 10, 50, and 70 μg/mL AgPyNP
treatments, respectively, for 24 h. This result indicated
that AgPyNPs was less cytotoxic compared to AgNPs.
Effect of AgNPs and AgPyNPs on ROS generation
The mechanism underlying the induction of inflamma-
tion by AgNPs and AgPyNPs may be through the gener-
ation of ROS. Therefore, the production of ROS was
measured by using fluorescence microscopy as well as
flow cytometry. Both the fluorescence microscopic
image (Figure 3a,b) and flow-cytometric data (Figure 4)
suggest that both AgNPs and AgPyNPs generate ROS in
a concentration-dependent manner, in which ROS gen-
eration increases with the increasing concentrations of
AgNP and AgPyNP. However, AgNPs produce more
ROS than AgPyNPs. Due to high cytotoxicity, the levels of
ROS production were reduced at high concentrations of
AgNPs and AgPyNPs (70 μg/mL). From the flow-
cytometric observation, it was clear for both 5 and 10 μg/
mL of AgNPs and AgPyNPs that almost the same amountFigure 2 AgNP- and AgPyNP-induced cytotoxicity in RAW264.7
cells was analysed using MTT assay. Cells were treated with
different concentrations of AgNP and AgPyNP for 24 h. The values
represent the mean of at least three independent experiments
normalized to untreated controls. Error bars represent the standard
deviations of three independent experiments. Student’s t-test was used
to determine the statistical significance: **P < 0.01; ***P < 0.001.
Presented data were combined from at least three experiments.
AgNPs, silver nanoparticles; AgPyNPs, nanosilver-pyridoxine complexes.of ROS was produced. Whereas, the peak of ROS pro-
duced by 50 μg/mL AgPyNP-treated cells (Figure 4)
was shifted towards the left compared to 50 μg/mL
AgNP-treated cells. After treatment of 70 μg/mL
AgPyNPs, the peak of ROS was shifted more towards
the left as compared to 70 μg/mL AgNP-treated cells.
This result signifies that, due to the antioxidant activity
of pyridoxine, the synthesized silver pyridoxine nano-
particles scavenge the ROS; thus, a smaller amount of
ROS production was observed in the case of AgPyNPs
compared to AgNPs.Assessment of IL-8 secretion
To assess IL-8 concentration in cell culture superna-
tants, ELISA was performed. As shown in Figure 5, IL-8
secretion was concentration-dependent. With increasing
concentrations of AgNPs and AgPyNPs, IL-8 secretion
also increased and reached a maximum at 50 μg/mL. At
50 μg/mL, IL-8 secretion was reduced due to toxicity
mediated by high concentrations of AgNPs and
AgPyNPs. In this case, AgPyNPs secreted more IL-8
than AgNPs. From Figure 5, it was clearly observed that,
up to 50 μg/mL, the IL-8 secretion was continuously in-
creased in a concentration-dependent manner for both
AgNP- and AgPyNP-treated cells; at 50 μg/mL, it de-
creased with increases in concentration of AgNPs, as
well as AgPyNPs. This decrease in IL-8 secretion was
due to the cytotoxicity of higher concentrations of both
AgNPs and AgPyNPs. However, for all of the concentra-
tions of AgPyNP treatment, the IL-8 secretion was
higher when compared with AgNP-treated cells. These
results indicated that AgPyNPs enhanced the immune
protection ability of macrophage cells by secreting more
IL-8 compared to AgNPs.Assessment of TNF-α, NF-κB p65, and NF-κB p50
expression
High-content cellular imaging cytometry was used to
analyse the expressions of TNF-α, NF-κB p65, and NF-
κB p50. As shown in Figure 6a,b, the expression of
TNF-α, NF-κB p65, and NF-κB p50 increased with
AgNP and AgPyNP treatments compared to that of un-
treated cells. Here, AgPyNPs exhibited a greater activa-
tion of TNF-α, NF-κB p65, and NF-κB p50 than AgNPs.
From Figure 6a,b, it was clearly observed that, for all of
the cases, the AgPyNP-treated cells phosphorylated
more TNF-α, NF-κB p65, and NF-κB p50 than AgNP-
treated cells. These results indicated that AgPyNPs
strengthened the inflammation response by activating
TNF-α and NF-κB and, thus, contributed to the en-
hancement of the wound-healing process better than
AgNPs.
Figure 3 Fluorescence and bar graph of AgNP- and AgPyNP-treated RAW264.7 cells. (a) Fluorescence microscopic analysis of ROS
generation in AgNP- and AgPyNP-treated RAW264.7 cells and scale bar represents 35 μm. (b) Bar graphs represent the mean ± SD intensity values
of triplicate treatment groups to analyse the ROS generation in AgNP- and AgPyNP-treated RAW264.7 cells. Error bars represent the standard deviations
of three independent experiments. Student’s t-test was used to determine the statistical significance: **P < 0.01; ***P < 0.001. Presented data
were combined from at least three experiments. AgNPs, silver nanoparticles; AgPyNPs, nanosilver-pyridoxine complexes.
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Nanotechnology is growing in importance for improv-
ing the quality of human life through its impact on
medicine and drug delivery systems. The antiseptic ac-
tion of silver has been well known for centuries. As a
result, this precious metal has long been used to treat
infectious diseases and heal wounds. Over the last dec-
ade, silver-nanoparticle-mediated therapeutic research
attracted the intense interest of many researchers.AgNPs promote wound-healing through their power-
ful antibacterial properties [23,24]. They induce inflam-
matory response on macrophage cells by releasing IL-8
[16]. Nanosilver particles and released ions from oxi-
dized nanosilver surfaces readily bind to sulfur- and
phosphorus-containing biomolecules, such as proteins
and DNA, thereby potentially causing cell damage [25-28].
This observed toxicity is also related to free radical (ROS)
formation that can damage the cell membrane [29]. Upon
Figure 4 Flow-cytometric analysis of ROS generation in AgNP- and AgPyNP-treated RAW264.7 cells. Peak shifts towards the right indicate
higher fluorescence intensities, which signify higher ROS production. Whereas, peak shifts towards the left indicate lower fluorescence intensities,
which signify lower ROS production. AgNPs, silver nanoparticles; AgPyNPs, nanosilver-pyridoxine complexes.
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further dissolved to Ag+ ions in the lysosomes due to the
lower pH found there. Such Ag+ ions could also interfere
with mitochondrial activity and induce cytotoxicity [30].
Therefore, in the present research, we prepared nanoparti-
cles consisting of a silver-pyridoxine complex to reduce
the undesired cytotoxicity of silver nanoparticles, as
pyridoxine possesses antioxidant activity [20] and also
enhances cell proliferation [21,22,31]. Observing the
considerable antimicrobial effects of AgPyNPs in our
laboratory (data not shown) lead to an increase in
interest in studying the cytotoxicity levels of AgPyNPs.
We compared the cytotoxicity and immune response of
AgNPs and AgPyNPs with respect to IL-8 secretion onFigure 5 IL-8 secretion in cell culture supernatants were
assessed by ELISA after AgNP and AgPyNP treatment in
RAW264.7 cells. The values represent the mean of at least three
independent experiments normalized to untreated controls. Error bars
represent the standard deviations of three independent experiments.
AgNPs, silver nanoparticles; AgPyNPs, nanosilver-pyridoxine complexes;
IL-8, interleukin-8.the macrophage RAW264.7 cell line. In our study,
AgPyNPs showed less cytotoxicity on the macrophage
cell line RAW264.7 as compared to AgNPs, which is a
beneficial feature in producing primary defence by mac-
rophages for combating bacteria. Therefore, we further
analysed the ROS-production ability of AgPyNPs. From
our fluorescence microscopic investigation and flow-
cytometric analysis, it was clear that the ROS-production
ability of AgPyNPs in RAW264.7 cells was slightly inferior
compared to AgNPs. This inferior ROS production is due
to the antioxidative property of pyridoxine, which scav-
enges the ROS produced by silver ions [32]. These phe-
nomena motivate our in-depth study to analyse the
immune effect of AgPyNPs. Macrophages represent a
primary line of defence against foreign materials. The
macrophage phenotype generates ROS, as well as a
plethora of inflammatory cytokines that facilitate killing
of invading pathogens [33]. Tissue macrophages are
distributed throughout the whole body and secrete
large pools of cytokines when they encounter foreign
materials or pathogens. Cytokines are inflammatory
mediators produced during an immunological response.
An increase in the release of cytokines indicates that an
external stimulation of immune cells is occurring.
Among the cytokines participating in innate immunity,
IL-8 recruits neutrophils to acute inflammation sites. It
is reported that silver nanoparticles induce IL-8 secre-
tion [16,34]. In this current study, we found that
AgPyNPs induce more IL-8 secretion in RAW264.7
cells compared to AgNPs. This result suggests that
AgPyNPs have more ability to produce primary anti-
microbial immune defence than AgNPs. Compared to
AgNPs, the synthesized AgPyNPs showed less cytotox-
icity and also enhanced IL-8 in RAW264.7 cells. These
Figure 6 (See legend on next page.)
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Figure 6 Fluorescent images and bar graphs of AgNP- and AgPyNP-treated RAW264.7 cells. (a) Photographs represent TNF-α, NF-κB p65,
and NF-κB p50 activation after AgNp and AgPyNp treatment in RAW264.7 cells, and the scale bar represents 15 μm. Fluorescent images were
taken at 525 nm (TNF-α), 565 nm (NF-κB p65), or 625 nm (NF-κB p50). (b) Bar graphs represent the mean ± SD intensity values of triplicate
treatment groups to analyse the ROS generation in AgNP- and AgPyNP-treated RAW264.7 cells. Error bars represent the mean ± SD of three
independent experiments. Student’s t-test was used to determine the statistical significance: ***P < 0.001. Presented data were combined from at
least three experiments. AgNPs, silver nanoparticles; AgPyNPs, nanosilver-pyridoxine complexes; BF, bright field.
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cell proliferation activity of pyridoxine, the synthesized
AgPyNPs provided extra capability to macrophage cells
to further enhance the immune response to fight mi-
crobial infection by secreting IL-8, when compared
with AgNPs.
Pro-inflammatory genes, such as TNF-α and transcrip-
tion factor NF-κB, have been reported to induce the ex-
pression of the genes associated with immunological and
cellular defence systems [35,36]. There have also been
some reports that suggest that carbon black nanoparti-
cles and silica nanoparticles have the ability to induce
inflammatory response by activation of NF-κB in macro-
phages [37]. Therefore, in our present study, we analysed
the expressions of TNF-α and NF-κB as an upstream
event of nanoparticle-induced inflammatory response in
macrophage cells using a high-content cellular imaging
cytometry method. Our screening method, based on
cellular imaging cytometry, provides simultaneous moni-
toring of cellular events and facilitates quantitative
multivariate cellular analysis with the elimination of false
positive errors, as it provides high-spectral resolution
among the fluorophores. Our results revealed that
expressions of TNF-α, NF-κB p65, and NF-κB p50 were
increased with treatment of both AgNPs, as well as
AgPyNPs, compared to control. These results demon-
strated that AgNPs/AgPyNPs significantly increase the
translocation of p65 and p50 subunits of NF-κB to
nucleus. Thus, inflammatory response in RAW264.7
cells is induced and facilitates the release of IL-8. Then,
we compared the expressions of TNF-α, NF-κB p65, and
NF-κB p50 after AgNP and AgPyNP treatment in
macrophage cells. Here, we also found that AgPyNPs
induced TNF-α, NF-κB p65, and NF-κB p50 expressions
better than AgNPs. As revealed in earlier studies [22,31],
pyridoxine helps to enhance the cellular proliferation of
macrophage cells, which leads to an increased immune
response. Their studies revealed the enhanced inhibition
of microbial infection as a result of strengthened im-
mune response by pyridoxine. In accordance with the
previous studies, it is thought that AgPyNPs possessing
pyridoxine domain showed greater immune response to
combat microbial infections by activation of NF-κB,
which helps to release more IL-8 and TNF-α as com-
pared to AgNPs.Conclusions
Overall results demonstrate that silver pyridoxine nano-
particles exhibit a better immunological response with low
cytotoxicity compared to silver nanoparticles, which is a
powerfully beneficial feature to heal wounds and
infection-related issues. Due to its antioxidant property,
silver pyridoxine nanoparticles generate a lesser amount
of ROS that produce oxidative stress in phagocytic cells,
such as macrophage. Thus, silver pyridoxine nanoparticles
help macrophages secrete more IL-8, which is implicated
in inflammation and postnatal wound-healing. IL-8 leads
to increased reepithelialization of wounds by stimulating
keratinocyte proliferation and migration [38]. Therefore, it
can be concluded that the newly formulated silver pyri-
doxine nanoparticles exhibit better therapeutic ability
compared to silver nanoparticles for treating and healing
wounds.
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